Medicus Pharma Ltd. (MDCX)
Nasdaq: MDCX · Pharmaceutical Preparations · W. Conshohocken, PA · filing with the SEC since 2023
Who runs Medicus Pharma Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Bokhari Raza
Chief Executive Officer. First filing Dec 2024, latest Sep 8, 2026, 0 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
15 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bokhari Raza | Chief Executive Officer | Dec 2024 | Sep 8, 2026 | none |
| Bonner Carolyn F. | President and CFO | Dec 2024 | Sep 8, 2026 | none |
| Smith Andrew Alasdair | Chief Operating Officer | Jul 2025 | Sep 8, 2026 | none |
| Brennan Edward J. | Chief Scientific Officer | Dec 2024 | Sep 8, 2026 | none |
| Mehmud Faisal | Chief Medical Officer | Dec 2024 | Sep 8, 2026 | none |
| Quinlan James P. | Chief Financial Officer | Dec 2024 | Aug 14, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ashton William | director | Dec 2024 | Jun 4, 2026 | none |
| Ciaruffoli Robert J. | director | Dec 2024 | Jun 4, 2026 | none |
| Fishman Barry | director | Dec 2024 | Jun 4, 2026 | none |
| Kaiser Larry | director | Dec 2024 | Jun 4, 2026 | none |
| Mahaffy Patrick J | director | Sep 2025 | Jun 4, 2026 | none |
| May Sara R. | director | Dec 2024 | Jun 4, 2026 | none |
| Raju Ajay | director | Dec 2024 | Jun 4, 2026 | none |
| Rodgers Cathy Mcmorris | director | Jul 2025 | Jun 4, 2026 | none |
Earlier names on the record5, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.